
The company behind Timberland, Vans and The North Face is on the lookout for further acquisitions despite coronavirus uncertainty, saying it could be a good time to expand its collection of clothing, footwear and accessories brands, reported the Financial Times.
“In times like this, some of the greatest returns could be generated through acquiring,” Steve Rendle, chairman and chief executive of New York-listed VF Corp, said in an interview.
While he made clear that organic growth was VF’s biggest priority, Mr Rendle said he saw potential opportunities to buy smaller rivals in subsectors including athleisure, outdoor and activewear.
Analysts said Canada Goose, Gap’s Athleta and Columbia Sportswear could be among the types of targets for VF, which has a market capitalisation of $24bn. Mr Rendle did not comment on any particular company. Coronavirus has caused a slump in global dealmaking, and the total mergers and acquisitions value of $955bn so far in 2020 is the lowest since 2013.
There have been some transactions in sectors such as technology, but concern about the outlook for consumer spending has made buyers reluctant to swoop on retail and consumer companies. Total deal value in the sector of $96bn is the slowest since 2010, according to Refinitiv.
Full Content: Financial Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas